LZVO Newsletter

The Latvian Medicines Verification System (LZVS) has successfully passed all compatibility tests so that the Latvian national system is prepared for European Medicines Verification System (EU Hub) updates / system release 1.9. LZVS is ready to work without interruption and restriction

EMVO remind that even if a product has a (EU) wide authorisation, i.e. licensed in many markets, data should only be uploaded to the EMVS for markets where the product in question is actively being marketed.

In the first quarter of 2021, in the medicines verification system, which guarantees the safety and authenticity of prescription medicines, 5.8 million packages of medicines were verified and have reached consumers.

Tā kā farmācijas uzņēmums “Pfizer” trešdien ir apstiprinājis, ka Meksikā un Polijā ir konstatētas un konfiscētas viltotas Covid-19 vakcīnas, Latvijas Zāļu verifikācijas organizācija (LZVO) aicina visus vakcīnu piegādes procesā iesaistītos pievērst īpašu uzmanību vakcīnu iepakojumam.

In 2020, the Latvian Medicines Verification Organisation (LZVO) has ensured the stable operation of the medicines verification system.

On March 16, new releases were deployed to the Core system of the Latvian medicines verification system (LZVS) and Reporting system.

Zāļu valsts aģentūra un Veselības inspekciju aicina būt piesardzīgiem un iegādāties zāles tikai licencētās interneta vietnēs.

The verification system in Latvia to prevent falsified medicines reaching patients has been fully operational for two years – a total of 22 million packages of medicines in Latvia have been checked by the system and delivered to the patients within 2020

The Latvian Medicines Verification Organization (LZVO) has supplemented its registered client portal with a new module, which is intended for system end users in Latvia